From India to Gothenburg via the UK

Image: L. Genborg

Bindhu, Aditi and Vidya
A new life in Gothenburg. It is November 2010 and Bindhu Gururajan and Vidya Sudheendara jump on a flight to Gothenburg. They are going on a four-day trip to help them decide if they should relocate to Sweden.Bindhu, an AstraZeneca employee since 2006, has been offered a senior scientist position in Mölndal.
Over the next four-days the pair exploresGothenburg and its offerings, visit two English language schools and have meetings concerning housing, job opportunities for Vidya, the Swedish tax system and cost of living.
"To be honest, at first I didn't want to come to Sweden because it was a big change for me. But after the visit, I said let's move. It was so beautiful, I really like Gothenburg," says Vidya.
Eightmonths later husband and wife packup their life in Leicester and along with their three-year-old daughter Aditi they make the big move to Gothenburg.
"For Aditi we think it will be a really nice environment to grow up in. That was one of the main factors in our decision to move here," says Vidya.
The family has lived in Gothenburg since July 27, about seven weeks. Both Bindhu and Vidya say that they feel welcome in the city, not only by Bindhu's colleagues, but also by their Hagen neighbours, parents at their daughter's preschool and even people on the tram. The friendliness of the people is something that took them by surprise.
"Especially at Aditi's school, her classmates' mothers, they are so interested. Where do you come from? What language do you speak?" says Vidya.
"Some of my colleagues have even offered me use of their summer houses. We are not used to that," says Bindhu.
The transition into Swedish life has been relatively smooth and AstraZeneca and their relocation company have helped streamline the process.Aditi is in a school that she loves, Vidya is studying Swedish, they love their home in Hagen and things such as an identity card, bank accounts and internet are all organized.
"It's really been a trouble free move," says Bindhu.
In four weeks Vidya and Aditi are off to Chennai, India, for three months. Vidya hasn't seen her family in two years. Upon return to Gothenburg she says learning the language and finding a job will be a priority.
"I want to work in admin. I've always worked in administration, but they [the relocation company] say I'll need to learn Swedish," says Vidya.
"I have three colleagues whose families moved here just a few weeks ago and they got jobs," says Bindhu.
"AstraZeneca has a scheme where a consultant helps with drafting your CV. If it is a science-based job, which was the case with a couple of colleagues' partners, they got jobs in Astra Zeneca. One guy got offered a job at Volvo and one girl got a teaching job at an international school. So I don't think it's difficult depending on the sector and your drive to look for jobs."
Lifestyle is one of the things Bindhu and Vidya are very happy with in Gothenburg. In particular they enjoy the closeness to water and forests, the parks for their daughter, the fresh food, the café culture and the active lifestyle of the locals.
The family enjoys spending their spare-time in Gothenburg. But at the same time Gothenburg's accessibility to Scandinavia, other parts of Europe and even Russia is something that Bindhu and Vidya have been, and plan on, making the most of.
"This weekend was Stockholm. Next weekend we go to Oslo," says Bindhu. "We are very keen to explore Finland, Iceland and Norway. I'm also persuading my wife that we should visit St Petersburg. It is not so far from here."
Bindhu appreciates the Swedish emphasis on work-life balance. If Aditi falls sick, which is not uncommon amongst three-year-olds, he says there is flexibility in his job to put her first.
He also enjoys and sees the importance of the regular "fika" breaks.
"In this country you go to work and naturally you take a fika break. In the Hindu culture, we are taught that you should have a mental break every three to four hours," says Bindhu.
Compared with working in India and the UK, he thinks AstraZeneca's Mölndal facility is a relatively relaxed and low-stress environment. At the same time he says the research is of the highest order and the drugs being developed are among the best on the market.
"A lot of innovative things happen in this facility. It's quite amazing."
The work environment is also very international. In Bindhu's department about 43 percent are newcomers from all over Europe, America and Asia. As far as he is aware, none of his colleagues regret relocating to Gothenburg.
"One guy has kids about 12 and 14 years-old. He's already thinking about universities in Sweden," says Bindhu.
After seven weeks in the city, the young family is happy they made the move from the UK to Sweden. Early concerns of the language, schools and a new life have faded. They expect to stay in Gothenburg at least four to five years to get the "local feel" and make the most of their Sweden experience.
This article was created in collaboration with AstraZeneca

In collaboration with AstraZeneca |
 |
 |  |
US patent approval for Promimic

The Gothenburg-based medical device company Promimic has obtained US patent approval for its thin implant coating HAnano...
More
|
 |
 |  |
Billion dollar acquisition for AstraZeneca

AstraZeneca is acquiring American bio technology company Ardea Biosciences for 1 billion US dollars, around 6.7 billion...
More
|
 |
 |  |
Meet Wayne - the expat who stayed
"I sort of got asked ‘Would you be interested to go and work in our sister site in Sweden for two years? ´ I sort of thought, why not."
More
|
 |
 |  |
New Strokefinder ready for clinical study

The first generation of Medfield Diagnostics' supervisory Strokefinder is now ready to be part of a clinical study of...
More
|
 |
 |  |
"Mölndal facility stands strong"

AstraZeneca's Mölndal facility stands strong. This is Karin Wingstrand's, VP and Head of Clinical Development, main...
More
|
 |
 |  |
Broken heart: researchers look for answers

Can you die from a broken heart? Yes, it's possible, but most people survive. A team of heart researchers at the Sahlgrenska...
More
|
 |
 |  |
New collaboration to increase clinical trials

Region Västra Götaland (VGR) wants more clinical trials to take place in the county. It has entered a...
More
|
 |
 |  |
Meet Arvid - Gothenburg's Nobel prize winner

The discoveries of Arvid Carlsson have been crucial for our understanding of brain function. They have also ...
More
|
 |
 |  |
AstraZeneca names Leif Johansson as new chairman

Former Volvo boss Leif Johansson is the proposed next chairman of AstraZeneca. The AstraZeneca board has proposed he takes...
More
|
 |
 |  |
Pierre Guyot: embrace diversity

Pierre Guyot is the Parisian who moved to Gothenburg, and likes it. Now the CEO of Mölnlycke Health Care, Pierre has...
More
|
 |
 |  |
First patients trial cancer vaccine

Gothenburg-based Immunicum has begun phase I/II clinical trials on the first patients for its cancer vaccine.
In total 12...
More
|
 |
 |  |
GU researchers give hope to infertile women

Researchers at the University of Gothenburg (GU) have made a discovery that could help women who have difficulties...
More
|
 |
 |  |
Mölnlycke buys US Brennen Medical

Med-tech. Gothenburg-based Mölnlycke Health Care has acquired American burn and wound care business Brennen Medical.
More
|
 |
 |  |
Encubator enters new collaboration with AstraZeneca

Business incubator Encubator AB has entered a new collaboration with pharmaceutical giant AstraZeneca. The project, which...
More
|
 |
 |  |
Large study can save many hearts

On Valentine's Day, February 14, begins a large heart study at the Sahlgrenska University Hospital. 1,000 Gothenburgers...
More
|
 |
 |  |
Cultivated corneas - new method in Gothenburg

Cultivated corneas may become reality. Researchers at the University of Gothenburg have been able to grow stem cells on...
More
|
 |
 |  |
Stem cell researcher awarded grant from Brain Foundation

Gothenburg stem cell researcher Charlotta Lindwall has received a research grant for 280,000 kronor from the Swedish Brain...
More
|
 |
 |  |
Life Science a prioritzed cluster in West Sweden

The Life Science sector in West Sweden has been identified as one of five prioritized clusters by leading representatives...
More
|
 |
 |  |
10 million kronor to cardiac disease research in Gbg

Three cardiac disease researchers at the Sahlgrenska Academy and the Sahlgrenska Hosptial in Gothenburg have been granted...
More
|
 |
 |  |
International award to Medfield Diagnostics

Gothenburg based life science company Medfield Diagnostics has won an international design award for their stroke helmet,...
More
|
 |
 |  |
From India to Gothenburg via the UK
A new life in Gothenburg. It is November 2010 and Bindhu Gururajan and Vidya Sudheendara jump on a flight to Gothenburg...
More
|
 |
 |  |
Gothenburg researchers discover new tick-borne infectious disease

Researchers at the Sahlgrenska Academy in Gothenburg have discovered a new tick-borne infectious disease. Only eight cases...
More
|
 |
 |  |
New drug can help insomnia sufferers

A new drug is offering hope to sufferers of insomnia. An extensive clinical trial, which included patients in Gothenburg,...
More
|
 |
 |  |
Brilique listed as major research development

AstraZeneca's new heart-drug, Brilique (ticagrelor tablets) is one of this year's most important research developments,...
More
|
 |
 |  |
AstraZeneca to build factory in China

Pharmaceutical company AstraZeneca will invest around 1.4 billion kronor (200 million dollar), in a new factory in China....
More
|
 |
 |  |
ESC recommends Brilique in new guidelines

AstraZeneca's new heart-drug, Brilique (ticagrelor), has been recommended for treatment of acute coronary syndrome (ACS) by...
More
|
 |
 |  |
AstraZeneca breast cancer drug receives approval in Japan

AstraZeneca's Faslodex 500mg has received regulatory approval in Japan, for the treatment of postmenopausal women with...
More
|
 |
 |  |
Park Annual 2011: innovation, sustainability and democracy

Park Annual is one of the largest life science events in the Gothenburg calendar. The seventh edition of the event took...
More
|
 |
 |  |
French biotech company to buy Cellartis

Gothenburg stem cell company Cellartis announced on Thursday that it is to be acquired by French biotech company Cellectis.
More
|
 |
 |  |
New heart drug from AstraZeneca

AstraZeneca announced on Tuesday that its heart drug Axanum has received positive agreement for approval in 23 EU countries,...
More
|
 |
 |  |
4.9 million kronor to local life science companies

Four Gothenburg-based companies active in life science have received almost 5 million kronor in funding from the VINNOVA...
More
|
 |
 |  |
Opportunities and challenges for the life science sector: new report

Gothenburg and Västra Götaland needs to strengthen its brand to become more attractive to those seeking employment...
More
|
 |
 |  |
At least 100 new jobs to AstraZeneca

230 people will move from AstraZeneca in Lund to Mölndal. But there are still about 100 positions that need to be...
More
|
 |
 |  |
Life Science: "Advantages of West Sweden should be better known"

Ingvar Carlsson, the former Social Democratic Prime Minister of Sweden, was recently appointed by Region Västra Gö...
More
|
 |
 |  |
Former PM to coordinate Life Science sector

Former Prime Minister of Sweden, Ingvar Carlsson, will be in charge of a new Life Science coordination project in Vä...
More
|
|